Article Details

"World-class Bispecific Antibody Technology of ABL Bio" - KED Global

Retrieved on: 2023-11-13 03:05:53

Tags for this article:

Click the tags to see associated articles and topics

"World-class Bispecific Antibody Technology of ABL Bio" - KED Global. View article details on hiswai:

Excerpt

John Hayslip, Chief Medical Officer of I-MAB Biopharma MADRID - "The clinical Phase 1 ...

Article found on: www.kedglobal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo